This topic contains a solution. Click here to go to the answer

Author Question: A 27-year-old male lung transplant patient developed Kaposi sarcoma (KS). The nurse knows that the ... (Read 60 times)

kellyjaisingh

  • Hero Member
  • *****
  • Posts: 540
A 27-year-old male lung transplant patient developed Kaposi sarcoma (KS). The nurse knows that the cause of this patient's KS is most likely related to the fact that the patient:
 
  a. is malnourished.
  b. was exposed to hepatitis B.
  c. is immunosuppressed.
  d. was diagnosed with cystic fibrosis.

Question 2

A 52-year-old female diagnosed with systemic scleroderma is at risk for which complication?
 
  a. Cutaneous vasculitis
  b. Raynaud phenomenon
  c. Cellulitis
  d. Infection



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

princessflame2016

  • Sr. Member
  • ****
  • Posts: 298
Answer to Question 1

ANS: C
KS is a vascular malignancy associated with immunodeficiency states and occurs among trans-plant recipients taking immunosuppressive drugs. KS is not directly related to malnourishment, exposure to hepatitis B, or being diagnosed with cystic fibrosis.

Answer to Question 2

ANS: B
Scleroderma can trigger Raynaud phenomenon. Scleroderma is not associated with vasculitis, cellulitis, or infection.




kellyjaisingh

  • Member
  • Posts: 540
Reply 2 on: Jun 25, 2018
Excellent


sailorcrescent

  • Member
  • Posts: 334
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

Did you know?

Many of the drugs used by neuroscientists are derived from toxic plants and venomous animals (such as snakes, spiders, snails, and puffer fish).

Did you know?

Your heart beats over 36 million times a year.

Did you know?

Only one in 10 cancer deaths is caused by the primary tumor. The vast majority of cancer mortality is caused by cells breaking away from the main tumor and metastasizing to other parts of the body, such as the brain, bones, or liver.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library